Cryo-Cell International: Overlooked Duke Contract Signals Business Inflection

luismmolina/E+ via Getty Images
Executive Summary
Cryo-Cell (OTCPK:CCEL) is undervalued with a potential 2-7x return on investment within 1-3 years. The money-making opportunity exists because of the company’s nano-cap size and the CEO’s furtive handling…

Click here to view the original article.